Plexus/$PLXS
1D1W1MYTD1Y5YMAX
Capital at risk
About Plexus
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
- Ticker
- $PLXS
- Sector
- Digital Hardware
- Primary listing
- NASDAQ
- Employees
- 20,000
- Headquarters
- Neenah, United States
- Website
- www.plexus.com
Plexus Metrics
BasicAdvanced
$6.8B
37.70
$6.77
0.89
-
Price and volume
Market cap
$6.8B
Beta
0.89
52-week high
$307.06
52-week low
$132.03
Average daily volume
238K
Financial strength
Current ratio
1.488
Quick ratio
0.67
Long term debt to equity
7.557
Total debt to equity
20.079
Interest coverage (TTM)
17.91%
Profitability
EBITDA (TTM)
307.106
Gross margin (TTM)
10.04%
Net profit margin (TTM)
4.03%
Operating margin (TTM)
5.01%
Effective tax rate (TTM)
13.77%
Revenue per employee (TTM)
$230,000
Management effectiveness
Return on assets (TTM)
4.26%
Return on equity (TTM)
12.58%
Valuation
Price to earnings (TTM)
37.699
Price to revenue (TTM)
1.488
Price to book
4.46
Price to tangible book (TTM)
4.46
Price to free cash flow (TTM)
110.536
Free cash flow yield (TTM)
0.90%
Free cash flow per share (TTM)
2.31
Growth
Revenue change (TTM)
14.20%
Earnings per share change (TTM)
15.37%
3-year revenue growth (CAGR)
2.17%
10-year revenue growth (CAGR)
5.98%
3-year earnings per share growth (CAGR)
8.62%
10-year earnings per share growth (CAGR)
11.07%
What the Analysts think about Plexus
Analyst ratings (Buy, Hold, Sell) for Plexus stock.
Analyst projections of the future price of Plexus stock.
Bulls say / Bears say
Q2 revenue of $1.164 billion topped IBES estimate of $1.131 billion, marking 19% year-over-year growth and exceeding guidance. (Reuters)
Plexus won a record 30 manufacturing programs representing $355 million in annualized revenue, bolstering its future growth pipeline. (SEC)
The company generated $16 million in free cash flow and improved its cash cycle to 64 days, delivering a 13.8% ROIC, well above its 9.0% cost of capital. (SEC)
Top 10 customers comprised 54% of Q2F26 revenue, up two percentage points from Q1, heightening customer concentration risk. (SEC)
Fiscal Q3 GAAP operating margin is guided to 4.1–4.5%, down from 5.3% in Q2, signaling potential margin compression. (Reuters)
Management now expects fiscal 2026 free cash flow of only $50–75 million, modest relative to its revenue scale, potentially constraining reinvestment capacity. (SEC)
Data summarised monthly by Lightyear AI. Last updated on 6 Sept 2026.
Plexus Financial Performance
Revenues and expenses
Plexus Earnings Performance
Company profitability
Upcoming events
No upcoming events
Plexus News
AllArticlesVideos
Funds containing Plexus
AllUSDGBPEUR
Fund name | Fund size | $PLXS weighting |
|---|---|---|
iShares S&P SmallCap 600$IDP6 | $3.2B | 0.37% |
iShares S&P Small Cap 600£ISP6 | £2.4B | 0.37% |
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.22% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | €2.8B | 0.18% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | £2.4B | 0.18% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.